October 8, 2021


by: admin


Tags: Acetaminophen, cells, controversy, exome, sequencing, Spectrum, Spotted, stem, web


Categories: autism

Noticed across the net: Acetaminophen, exome sequencing, stem cells controversy | Spectrum

Research summary

  • People with FOXP1 syndrome, which is characterized by intellectual retardation and developmental delay, may also have autism, attention deficit hyperactivity disorder, and anxiety. Molecular Autism
  • Pairs of twins in which one twin is autistic had more obstetric complications than non-autistic twins, according to a new meta-analysis, although complicated births and autism may have underlying familial factors in common. Journal of Child Psychology and Psychiatry
  • Paracetamol use during pregnancy has been linked to having a child with a neurodevelopmental disorder such as attention deficit disorder or autism, according to a review of 25 years of research. Spectrum covered some of that research in 2019. The conversation
  • People with 22q11.2 deletion syndrome, which is linked to schizophrenia and autism, may have a leaky blood-brain barrier, according to findings in a model system grown in the laboratory. Cells
  • Children with tuberous sclerosis have different electroencephalogram profiles depending on whether they have mutations in the TCS1 or TCS2 gene, and these profiles correlate with characteristics of autism. Developmental Medicine & Child Neurology
  • Mice lacking the autism-related CNTNAP2 gene have altered sensory processing and altered neuronal fire in the cerebellum. eNeuro
  • According to a report from Israel, exome sequencing is a useful diagnostic tool in the real-world clinical setting. Scientific reports

Science and society

  • A 10-year plan to improve the lives of autistic people in Scotland has made some improvements, but 72 percent of autistic people and their families still have unmet needs for care, education and employment. National Autistic Society
  • The U.S. Food and Drug Administration canceled GTX-102, an experimental drug treatment for Angelman syndrome, after manufacturers agreed to test lower doses. Spectrum covered the hiatus last year and the restart this week. BioPharma dive
  • The coronavirus pandemic has spurred change that disability advocates have long fought for and new hope that this protection will be extended to those who do not identify as disabled. The New York Times
  • Too often, neuroscientific studies only use male participants or animals based on outdated and false beliefs that the data collected from women is more variable. Spectrum reported on the inclusion of female animals in autism research in 2015. The Scientist
  • YouTube has stepped up its crackdown on misinformation about COVID-19 vaccines to ban videos of vaccine falsehoods, such as: B. About Autism. Disability scoop
  • Four disabled researchers share their strategies for working in an ableist world. nature
  • Paying research participants is neither the only nor the best way to increase recruitment, writes the chief medical officer of a data analytics company. STAT
  • Cryo-Cell International, a cord blood bank company working with Duke University, plans to open infusion centers to sell its previously unproven stem cell therapy to autistic children. Spectrum has extensively covered the controversy over stem cells for autism and reported ambiguous clinical trial results from Duke last year. Vice

Quote this article: https://doi.org/10.53053/ZYJP4782


Don’t miss these tips!

We don’t spam! Read our privacy policy for more info.